Effect of curcumin (tumeric) on patients with Metabolic syndrome

Clinical trial of curcumin effect on patients with Metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201512181165N12

Enrollment

100

Registered

2017-10-27

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Other postprocedural endocrine and metabolic disorder

Interventions

Intervention 1: Intervention group: Curcumin capsule, once a day for 3 months. Intervention 2: Control group: Placebo of curcumin, once a day for 3 months.

Treatment - Drugs

Placebo

Intervention group: Curcumin capsule, once a day for 3 months

Control group: Placebo of curcumin, once a day for 3 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients with metabolic syndrome; Sign informed consent Exclusion Criteria: Discontinue of treatment for more than One week; Allergic reaction to herbal compounds; Abnormal results in lab tests

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood Pressure. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mmHg.;FBS. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;TG. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;HDL. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;LDL. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;Small Density LDL. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;Interleukin 8. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Level of serum.;Interleukin 6. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Level of serum.;Hb A1C. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Level of serum.;Leptin. Timepoint: Before and after of intervention (12 weeks). Method of measurement: ng/ml.;Adiponectin. Timepoint: Before and after of intervention (12 weeks). Method of measurement: ng/ml.;Leptin/Adiponectin Ratio. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Ratio.	—

Measure

Time frame

Blood Pressure. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mmHg.;FBS. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;TG. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;HDL. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;LDL. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;Small Density LDL. Timepoint: Before and after of intervention (12 weeks). Method of measurement: mg/dl.;Interleukin 8. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Level of serum.;Interleukin 6. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Level of serum.;Hb A1C. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Level of serum.;Leptin. Timepoint: Before and after of intervention (12 weeks). Method of measurement: ng/ml.;Adiponectin. Timepoint: Before and after of intervention (12 weeks). Method of measurement: ng/ml.;Leptin/Adiponectin Ratio. Timepoint: Before and after of intervention (12 weeks). Method of measurement: Ratio.

—

Secondary

Measure	Time frame
Body Mass Index (BMI). Timepoint: Before and after of intervention (12 weeks). Method of measurement: Kg/m2.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloufar Torabi

Pharmaceutical Sciences Branch Islamic Azad University

y_niloo@yahoo.com+98 21 2264 0051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026